Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: INSP stock price vs WFC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WFC's multiple
Needs WFC P/E.
Implied fair value · at INSP's multiple
Needs INSP P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INSP FY 2025 (ended Dec 31, 2025) · WFC FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 1.79x · EV / EBITDA 24.73x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 59% equity / 41% debt
WFC carries the larger enterprise value at $465.16B against $1.63B; INSP trades on the lower EV / Revenue multiple (1.79x vs 5.33x); WFC on the lower EV / EBITDA (7.16x vs 24.73x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Inspire Medical Systems, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
WELLS FARGO & COMPANY/MN · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.14x
1.07x
Net debt / EBITDA
Leverage against operating earnings
-2.98x
—
Cash and equivalents
Liquid reserves on the balance sheet
$308.27M
—
Total debt
Interest-bearing obligations outstanding
$112.36M
$193.04B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BOSTON SCIENTIFIC CORP
INSP vs BSX
Medtronic plc
INSP vs MDT
ABBOTT LABORATORIES
INSP vs ABT
JOHNSON & JOHNSON
INSP vs JNJ
LivaNova PLC
INSP vs LIVN
JPMorgan Chase & Co.
INSP vs JPM
Bank of America Corporation
INSP vs BAC
Citigroup Inc.
INSP vs C
The Goldman Sachs Group, Inc.
INSP vs GS
Morgan Stanley
INSP vs MS
Capital One Financial Corporation
INSP vs COF
TRUIST FINANCIAL CORP
INSP vs TFC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
